"Proteinuria" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The presence of proteins in the urine, an indicator of KIDNEY DISEASES.
| Descriptor ID |
D011507
|
| MeSH Number(s) |
C12.777.934.734 C13.351.968.934.734 C23.888.942.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Proteinuria".
Below are MeSH descriptors whose meaning is more specific than "Proteinuria".
This graph shows the total number of publications written about "Proteinuria" by people in this website by year, and whether "Proteinuria" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 3 | 0 | 3 |
| 2004 | 0 | 3 | 3 |
| 2005 | 2 | 2 | 4 |
| 2006 | 1 | 4 | 5 |
| 2007 | 3 | 2 | 5 |
| 2008 | 1 | 4 | 5 |
| 2009 | 0 | 3 | 3 |
| 2010 | 2 | 4 | 6 |
| 2011 | 0 | 2 | 2 |
| 2012 | 2 | 5 | 7 |
| 2013 | 0 | 2 | 2 |
| 2014 | 1 | 3 | 4 |
| 2015 | 0 | 2 | 2 |
| 2016 | 2 | 0 | 2 |
| 2017 | 2 | 0 | 2 |
| 2018 | 0 | 2 | 2 |
| 2019 | 2 | 1 | 3 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proteinuria" by people in Profiles.
-
High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines Partnership. Rheumatology (Oxford). 2022 11 02; 61(11):4335-4343.
-
Nitric-Oxide-Mediated Signaling in Podocyte Pathophysiology. Biomolecules. 2022 05 25; 12(6).
-
Prediction models of treatment response in lupus nephritis. Kidney Int. 2022 02; 101(2):379-389.
-
Camptothecin and Topotecan, Inhibitors of Transcription Factor Fli-1 and Topoisomerase, Markedly Ameliorate Lupus Nephritis in (NZB ? NZW)F1 Mice and Reduce the Production of Inflammatory Mediators in Human Renal Cells. Arthritis Rheumatol. 2021 08; 73(8):1478-1488.
-
Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice. PLoS One. 2020; 15(3):e0230499.
-
Impact of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on renal and mortality outcomes in people with Type 2 diabetes and proteinuria. Diabet Med. 2020 01; 37(1):44-52.
-
Disruption of the exocyst induces podocyte loss and dysfunction. J Biol Chem. 2019 06 28; 294(26):10104-10119.
-
The TNF-derived TIP peptide activates the epithelial sodium channel and ameliorates experimental nephrotoxic serum nephritis. Kidney Int. 2019 06; 95(6):1359-1372.
-
The diagnostic dilemma of new-onset crescentic glomerulonephritis following pre-eclampsia. Clin Nephrol. 2018 Dec; 90(6):434-436.
-
Novel mechanism for estrogen receptor alpha modulation of murine lupus. J Autoimmun. 2019 02; 97:59-69.